Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand

Author: Benzinga Newsdesk | October 06, 2025 03:40pm

Preliminary Results

On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results:

●

Achieved annual total product revenue of approximately $9.1 million.

●

Cash and cash equivalents of approximately $6.6 million at September 30, 2025.

Posted In: NMTC